Streptomyces fimbriatus (Millard and Burr) Waksman and Lechevalier
商品貨號
B183082
Strain Designations
SC-3683 [CBS 453.65, NRRL B-3175]
Application
Produces restriction endonuclease SfiI
Produces septacidin
Isolation
Soil, Las Vegas, NV
Biosafety Level
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format
freeze-dried
Disclosure
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC.
Dutcher JD, et al. Septacin, a new antitumor and antifungal antibiotic produced by Streptomyces fimbriatus. Antimicrob. Agents Chemother. 1963: 83-88, 1964.
Dutcher JD, et al. Septacidin and derivatives thereof. US Patent 3,155,647 dated Nov 3 1964
Qiang BQ, Schildkraut I. A type II restriction endonuclease with an eight nucleotide specificity from Streptomyces fimbriatus. Nucleic Acids Res. 12: 4507-4516, 1984. PubMed: 6330673
Skerman VB, et al. Approved lists of bacterial names. Int J Syst Bacteriol 30: 225-420, 1980.
Roberts RJList of known restriction endonucleasesIn: Roberts RJNew England Biolabs Catalog 1986/87pp. 68-81, 1987
